arrow_back Back Filing freshness 10-Q FY 2026 SEC EDGAR

download Export Data

PRECISION BIOSCIENCES INC

DTIL

$7.51 ▲ +0.11 (+1.49%) at close

9 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

PRECISION BIOSCIENCES INC faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $96.3M

Dividend Yield —

Revenue Growth -50.1% ↘

Op. Margin -152.2% ↘

ROIC -44.7% ↘

FCF / Share $-5.13 ↗

Trailing P/E —

Price / Book 2.0x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$34.26M

↓ -50.1% —

Net Income Profit after all expenses

$-45.72M

↓ -738.0% —

Operating Margin Operating profit as % of sales

-152.2%

↓ -299.6% 0th

FCF / Share Free cash flow per share

$-5.13

↑ +40.0% —

Long-Term Debt Long-term obligations

$22.22M

↑ +796.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile
Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns ↑

Financial Health ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	-50.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-727%)	41.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+412%)	94.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1077%)	-78.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1078%)	375.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4597%)	-97.7% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1322%)	9731.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+121548%)	—	—
EPS Growth YoY (%)	N/M	N/M	58.1% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-219707.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	45.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-264.8% Weak ↓ Weak Declining Year-over-year change in net income	71.9% Excellent ↑ Excellent Improving Year-over-year change in net income	-17.4% Weak Weak Year-over-year change in net income	-101.7% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	40.0% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	60.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-40.2% Weak Weak Year-over-year change in free cash flow	-253233.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—
Revenue CAGR 3Y (%)	10.9% Good ↑ Good Improving Compound annual revenue growth over 3 years	-15.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	26.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-71.4% Weak Weak Compound annual revenue growth over 3 years	119.8% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	7.1% Fair ↑ Fair Improving Compound annual revenue growth over 5 years	-42.3% Weak Weak Compound annual revenue growth over 5 years	35.0% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	-152.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1115%)	-38.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-354%)	-89.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-698%)	-248.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1755%)	-34.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-327%)	-452.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3115%)	-8.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-154%)	-440.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3035%)	—
Profit Margin (%) (%)	-133.4% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1212%)	10.4% Fair ↑ Fair Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-13%)	-125.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1149%)	-444.8% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3807%)	-26.5% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-321%)	-448.9% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3841%)	-8.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-172%)	-423.0% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3625%)	—
FCF Margin (%) (%)	-192.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-85.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-172.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-182.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-9.4% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-359.8% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-6.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-475.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	1.44x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	-8.15x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.37x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-44.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-36.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-183.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-59.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-195.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-94.7% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-33.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-26.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-73.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-34.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-49.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	12.7% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-15%)	—	-184.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1332%)	-33.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-324%)	-245.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1736%)	-67.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-548%)	-115.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-868%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	0.37x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-39%)	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	—	—	—	—
Interest Coverage (x)	-38.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-15.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-19.61x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-56.08x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-298.30x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-479.14x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-110.82M	$-85.90M	$-116.68M	$-167.35M	$-141.19M	$-89.80M	$-180.89M	$-103.19M	—
Debt / EBITDA (x)	—	—	—	-0.36x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.06x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$2.67	$10.05	$12.68	$8.57	$0.07	—	—	—	—
Basic EPS, GAAP (USD)	$-3.56	$1.05	$-15.96	$-38.10	$-0.02	—	—	—	—
Free Cash Flow per Share (USD)	$-5.13	$-8.55	$-21.90	$-15.62	$-0.01	—	—	—	—
Book Value per Share (USD)	$3.83	$6.87	$4.53	$16.34	$0.05	$0.03	$0.09	$0.08	—
Tangible Book Value per Share (USD)	$3.78	$6.80	$4.43	$16.14	$0.05	$0.03	$0.09	$0.08	—
Basic Weighted Avg Shares (shares)	12.83M	6.83M	3.84M	2.93M	1.76B	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Working Capital (USD)	$109.83M	$80.01M	$86.37M	$139.44M	$125.77M	$62.73M	$166.74M	$101.60M	—
LT Debt (USD)	—	—	—	$22.22M	$2.48M	—	—	—	—
Total Equity (USD)	$92.25M	$56.39M	$18.86M	$60.43M	$91.17M	$44.42M	$138.31M	$39.96M	$-26.37M

📋 What is driving earnings? 3 metrics

Metric	FY 2026 Dec 31, 2025 10-K ↗	FY 2025 Dec 31, 2024 10-K ↗	FY 2024 Dec 31, 2023 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$34.26M	$68.70M	$48.73M	$25.10M	$115.53M	$24.29M	$1.07B	$10.88M	—
Net Income, GAAP (USD)	$-45.72M	$7.17M	$-61.32M	$-111.64M	$-30.60M	$-109.01M	$-92.88M	$-46.04M	—
Operating Cash Flow (USD)	$-65.84M	$-58.45M	$-84.11M	$-45.75M	$-10.85M	$-87.39M	$-71.02M	$-51.72M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 36 quarters

PRECISION BIOSCIENCES INC

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare DTIL with peers